Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
MCC-21894
Phase 1 mab active
Quick answer
Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL) for Urothelial Carcinoma is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Urothelial Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active